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Abstract: Backgrcund: During the las1 two decades, research about GATA-3, Ki67. p53 enpressions have been done, but it is
still a debate on their use in predicting breasl cancer patients' prognosis and sunival rate. Eryressions of GATA-3 decreased witlt
increasing of histopatholory grading of brcas1 cancer and incrcase with decrease of histopathologl grading of breast cancer The
level expression of Ki-67 has a fnsitive relation with breast cancer hislopathology grading. p53 has no conelatron with high grade
differentiation of breast canc€r. p53 is a transcription factor which is activated as a part ofc€llular slress response that can regulate
genes' c€llular process, including apoptosis and senesc€nce. ,4irt; To deiermine correlation between expressions of GATA 3, Ki-67
and p53 with histopathology grading of brcast canc€r in Makasar, Indonesia. Met ods. Antibody monoclonal GATA 3, Ki-67 and
p53 on the nucleus cell were detected with immunohistochemislry method. The positive and negative expressions of GATA 3, Ki-
6? and p53 were assessed using scoring system according to the proponion of positive cell and coloring intensities. ReJtlrJ. There
is no correlation bet$e€n the higher positive ex?ression oS53 and higher expression of hi$opathology grading ofbreast cancer (P
= 0.089). While Ki67 had positive association with higher grade malignancy (P = 0.03). However, there was no assocratron
between GATA-3 expression and histopathology grading. Conclusion: In our research we found there is no corelation betweEn
higher exprcssion of p53 and low eryrcssion of GATA-3 with higher histopatholory grading of breast cancer. High eryression of
Ki67 have sgnificantly statistic analysis with high epression of histopathology grading of mammary cancer.
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1. Introduction
Breast cancer is a malignancy that ocflrs rn the breast
gland. Breast cancer ranks first of the ten types of cancer in
women. It rvas reported incidence of breast cancer in all over
the world increase twrce, this is the highest level during the
late 30 years. WHO predicted the incidence rate of all cancer
were 11 millions and every year the amount of breast cancer
increase to 7 millions.
In the United States in 2005 reported the incidence of breast
cancer by two hundred eleven thousands two hundred fourty
(211,240) new cases (ACS, 2006). In 2W7 the incidence of
breast cancer was reported increase to two hundred fourty
three thousands (243,000) with sixty tu.o thousands (62,000)
among them rvith Carcinoma In Situ (CIS). Breast cancer
incidence has rncreased every year. Data from the Amencan
Cancer Society in 2010. stated that there are two hundred
seven thousands ninety (207,090) new cass of breast cancer
in women in the USA with the estimated number of deaths
about thirry nine thousands eight hundred fourty (39,840)
cases []. This figure makes breast cancer as the second most
common cause of death in women after lung cancer.
In Indonesia the incidence of breast cancer reported twenty
thousands (20,000) new cases/year, around hundred (100)
cases among one hundred thousands (100,000) women. 50%
rvere hospitalized in late stages [!.
ln Wahidin Sudirohusodo Hospital in Makassar, Indonesia
the incidence of breast cancer in 2007 were 163 new cases
and became 189 new cases in 2008. There is increasing cases
of late stage of mammary cancer and metastatic stage from
69.9% in the year 2007 became 74.1% in the year of 2008
(Wahidin Sudirohusodo Hospital Information System).
Ki-67 expression as detected by immunohistochemistry is
one of the most vanable indicators of the proliferative status
of cancer cells and is referred to as Ki-67. In 2009 at the St-
Gallen breast cancer conference. Ki-67 rvas recommended as
a biomarker for prognosis and sensitivity of cancers to
endocrine therapy or chemotherapy [3]
Erpression of transcription factor GATA-3 has been sliown to
be important for normal breast glandular cell development as
well for maintaining the drfferentrated skte of cells [4].
Eryression of GATA-3 was sigrrificantly rncreased in breast
cancer. Decreasing of GATA-3 expressions correlate with
increasing tumor tustological grade and high patient survival [5].
Expression of p53 in higher differentiated with high
proliferation fraction may indicate greater tumor
aggressiveness and high risk of relapse [9] p53 is a critical
tumor suppressor that maintains the genetic stability in
mammals by having multrple roles in cells cycle arrest,
apoptosis, senescence and differentiation. Loss of p53
firnctions is required for the progression of most cancers. The
expression of mutant p53 is conelated with the poor prognosis.
The aim of our study was to investigate the expression of p53,
Ki{7 and GATA-3 in correlation with hisopathology grading
among 50 nested sampling in pathological anatomy laboratory
medical faculty in Makassar.
2. Methods
A total of 50 cases of breast cancer were studied in
laboratory of anatomic pathology Wahidin Sudirohusodo
general hoqpital Faculty of Medicine, Hasanuddin University
Makassar, Indonesia The research was perf'ormed from
October20l5 to November 2015 in women from 27 to 73
years old. Fresh tissue from biopsy or tumorectomy was
received in department of pathological anatomy and put in
buffered formalin solution.
2. 1. Hktopafhologt Grading Charucteristic
The histopathology grade was determrned in sections
stained with haematoxylin eosin according to the criteria
established and histological type according to the WHO
classification (1981).
2. 2. Immunohistochemical Study D etermination of
Expressions of Ki-67 and p53
Immunohistochemical analyses were determined by &e
expression levels of Ki-67 and p53. Tissues were fixed in
l0% formaldehyde for 24 hours, routinely embedded in
paraffin and cut into 5-pm sections. Sections were adherent
to APES coated slides and dried at 60oC for 2 hours [7, $].
Immunohistochemistry was performed accordrng to the
manufacturer's insFuctions, using Streptavidin-Peroxidase
(SP-9000) kit, anti Ki-67 (ZMol66), p53 (2M0408), C-erb2
(2M0065), all from Zymed laboratories (San Francisco, CA,
USA) with antigen retrieval performed according to the
manufacturer's instruction. The slides were scored by
counting the number of positive cells regardless of the
staining intensity versus the total number of cells and
calculating the percentage of positive cells (positive
cellVtotal cells in one field), as previously described, the
positivity of several frelds were averaged and expressed as
the ratio of positive cells per field to total cells per field:
<10o , negative, rc% - 20%'. weakly positive, 26% - 5A%.
positive, >sjo/o'. strcng positive. A cut-off point of 25Yo was
used to distinguish between the categories of low and high
proliferative tumors, a value similar to 20Yo or>20Yo P-l1l
2.3. Immunohistochemistry Staking hocedares of GAM-3
Tissue in paraffin blocks of sze 5-pm was cut and glued on
the slide poly-L-lysine and then carried. Immunohisto
chemical staining was using standard methods Avidin-Biotin
peroxidase Complex (ABC) Slide that has not been colored
was incubated in 0,1% trypsin solution in citrate buffer pH 6
for l0 minutes in the microwave with temperature 37oC. After
that examrration followed by standard procedure AIIC.
GATA-3 using GATA-3 monoclonal antibody, at a dilution of
l: 200 [12]. Results were evaluated by immunohistochemicai
staining using light microscope by 2 pathologists and
researchers. The expression of GATA-3 is the accumulation of
GATA-3 in the cell nucleus detected by immunohistochemical
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methods. Expression of GATA-3 positive when there is a
brown color in the cell nucleus that is seen with a light
microscope. Thrs expression is calculated using a sconng
system based on the proportion of positive cells and the
intensity of the color. Immunoexpression GATA-3 is e4pressed
in a semiquantitative estimation of the scoring system
perc€ntage. 0: No stained cell nucleus, 1: 1-10% stained, 2: I l-
2O%,3. 2l-3$/o, 4. 3l-4}oh, 5: 41-50Yo, 6: 5l-60Yo,7: 61-
7}yo, 8'. 7 | -80%, 9: 8 I -90%, l0: 9 I - 100%. Intansrty: I *: weak
intensity, 2+: moderate intensity, 3+: strong intensity. Last
score obtained by multiplying the intensity of the presentation
and the expression of GATA-3 in the cell nucleus to obtarn a
range of scores 0-30. Then was grouped again to Score 0-3
declared negative, Score 4-30 tested positive [3].
2. 4. Stulistical Analysis
All the data collection were recorded and then analyzedby
using software SPSS 17.0 to compare score expressions of
GATA-3, p53 and Ki-67 to scores of breast cancer
histopathology grading. Statistical analysis was using chi-
square test. P-value less &an 0.05 was considered
statistically si grificant.
3. Results
3,1. GATA-3, p53, Ki-67 hotein Expressi,on Patterns in
Breast Ttssue
I-igure I. Positive expresston of immunohistochemistry of GATA-3 (200 )t),
Ftgwe 2. Positive erpression of immunohistochemistry of Ki-67 1200 x).
-tt'I
Figure 3. Positive erpression ofimmunohistochemistr), ofp53 (200 x).
Characteristics of Samples. The total sample of 50 studies
examined in laboratory of Pathology Anatomy, Faculty of
Medicine. Hasanuddin Universitv. Makassar. Indonesia.
Toble L Charaoeristic Sarnpling oJ'the Research
Chamcteristics TotalGq Percentage
:4$YAge 
> 4o,*
Histopathology l,ow Differetrliated(hading High Differenrialed
Negative
Positive
Negative
Positil'e
Negative
Positive
24o'/o
76o/o
20o/o
6001o
460./o
54oto
34o/o
660h
300,6
70oto
t2
38
l0
40
L-t
27
l7
-t -t
l5
35
Protein p53
Protein Ki-67
GATA3
In table I the sample was mostly from more than 40 year
patients with a percentage of 76% or 38 out of 50 samples.
Low differentiated histopathology grading were 2oyo (10
cases) whrle high differentiated were 80% (40 cases). The
amount of p53 protein positive expressions were 54o/o (27
cases) where the negative p53 expression levels were 4604
(23 cases).
Ki-67 positive expressions were 66% (33 cases) and
negative expressions were 34Yo (17 cases). GATA-3 positive
expressions were 70% (35 cases), where negative
expressions were 30% (15 cases).
Tahle 2. Correlation Between The Expression Of Ki67 and HistopathologSt
Crading of Breast C anc er
Histopathologv (irarlin g
High
Ki-67
Positive
Negative
J
6,0oto
1
14,0o/o
10
20,v/o
27
54,Iot'o
t-J
26,00/o
40
80,0%
30
60,00h
)n
40,0o/o
50
l00,0qu'o
Total
[,ow
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6.090 48.0qir
Negarive 7 1614,0o'o 32.U/o
'Ibtal 10 40
20,0o,'o 80,096
Correlation between positive expressions Ki-67 with high
differentiated histopatholory grading were 54yo or 27 cases
out of 50 cases. While in low differentiated positive
expressions of Ki-67 were found in 3 cases with a percentage
of 6yo. The negative Ki-67 expressions were found in 13
cases (26%) with high differentiated histopathology grading.
While negative
Ki-67 expressions were found in 7 cases (14%) with lorv
differentiated histopa&ology grading.
Tdbk 3. Conelation Between p53 Expression and Histopathologlt Grading
ofBreast Cancer
Histopathology Gr:ndin g
higher histopathology gading in this research.
In the statistical test using chi-square test we found that P
was greater than 0.05 (P = 0.1 is not sigaificant). This
showed that the low negative expression of GATA-3 was not
significantly correlated with higher differentiated
histopathology grading in this research.
4. Discussion
The mutation of p53 gene is a common phenomenon in
numerous human tumors, leading to the accumulation of
nonfunctioning p53 protein in the cell nucleus, which can be
detected by Immunohistochemistry.
In breast cancer, it has been suggested that the over
expression of p53 protein in the nucleus is an indicator of
poor prognosis, which must be borne in mind rn selecting
coadjuvant treatment for each patient [14].
In our study we found a positive p53 expression in high
histologic grading is 48.0% among 50 cases and a negative
p53 expression rn 16 cases (32.0%) where in statistical
analysis there is no correlation between a high expression of
p53 and higher histologic grading of tumor (P = 0.039)
Sirvent, Salvado et al. study about IHC analysis of p53
expression in 153 cases of breast cancer, correlating with
histological grade, axillary node status, hormone receptors,
cell proliferation fraction and expression of the c-erB-2
oncoprotein. Of all the breast cancer tissue analyzed, 4397%
were positive p53, over expression of this protein show direct
statistically significant relationship to histological gade, cell
proliferation faction and c-erB-2, but had no statistically
significant relationship with axillary node status.
Mutation and the over expression of p53 protein are
directly related to histological grade [14].
GMA-3 is a nuclear of GATA-3 transcriptions regulatory
family and is important in directing cell fate. Development
and or differentiation in a member of cell types including
luminal epithelial cells of mammary gland. GATA-3 is a
member of the GMA-3 transcription regulatory family and is
important in directing cell fate, development, and or
dtfferentiation in a number of cell types including luminal
epithelial cells of the mammary gland. Although we and
others have shown that GATA-3 levels were generally higher
in malignant cells compared with morphologically normal
epithelium, witlun malignant tissue, relatively lower levels of
GATA-3 portended a poorer outcome compared with
relatively higher expression. Consistent with the role of
GATA-3 in the development and differentiation of normal
mammary epithelium, we further observed that lower levels
of GATA-3 were generally associated with a hrgher-grade,
less differentiated maligrancy [4].
In this study, we used a IHC to reassess associations of
GATA-3 expression with Histopathologic grading of 50
samples of breast cancer in Makassar. We found that positive
expression of GMA-3 had amount of 28 samples (28%)
among high histopathologic grading of breast cancer. Even
&ough the higher expression positive GATA-3 seen in high
histopathologrc grading but there is no statistically
)'7
54,ff/o
IJ
46,V/o
50
10a,00/o
Correlation of positive p53 with high differentiated
histopathology grading were 480/o (24 cases) while p53
negative with high differentiated histopathology grading
were32Yo (16 cases). A positive p53 expressions were found
in 3 cases with low differentrated histopathology grading
(6%). The percentage of negative p53 expressions with low
differentiated histopathology grading is 14% (7 cases.;.
Table 4. Correlation Between CAA3 Expression Mth Histopathotogt
Grading Of B reast C ancer
4istopatholog Grading
Lorr Hlgh
GATA3
Total
Negalive
7
14,00/6
6,0Vo
l0
20,Ooto
28
56,0%
ta
35
70.0o/o
15
30,00/o
50
lA0,0oto
24,00/o
40
84,096
Positive GATA-3 expressions were seen in high
diffsrentiated histopathology grading with a percentage of
56%, 28 among the 50 cases, while GATA-3 negative
expressions found in high differentiated histopathology
grading wrth a percentage of 24Yo or 12 cases. GATA-3 is
only visible negative 6% (3 cases) in low differentiated
histopathology gading. In low differentiated histopatholog.v
gmding, we found 7 cases with positive GATA3 expressions
(14%).
3. 2. S totistic al Analysis
In the statistical test using chi-square test, turned out tlat p
value was less than 0.05 (P = 0.03). This showed that the
higher the expression of Ki-67 the higher differentiated result
in histopathology grading.
In the statistical test using chi-square test we found that p
was greater than 0.05 (P : 0.089). Thrs sirows that the higher
expression of p53 was not correlated sigmficantly with the
TotalLow Hich
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significant correlation between them. Negative (low)
expression GMA-3 only had 12 samples among high level of
histologic grading (20%) of the result.
Mehra et al. fourrd low GATA-3 expression was associated
with higher histologic grade (P < 0.001), positive nodes (P =
0.002), larger tumor size (P = 0.03), negative estrogen
receptor and progesterone receptor (P < 0.001 for both) [5].
Ki-67 protein (also known as MKI67) is a cellular marker
for proliferation. This nuclear protein is expressed in
proliferatrng cells during Gl through M phases of the cell
cycle, but is not detected rn resting cells. The Ki-67
expression as detected by immunohistochemistry is one of
the most reliable indicators of the proliferative status of
canc€r cells and is referred to as Ki-67 henceforward. In
2009, at the St-Gallen breast cancer conference, Ki-67 was
recommended as a biomarker for prognosis and sensitivity of
cancer cells to endocrine therapy or chemotherapy. In 201I,
Ki-67 was regarded as one of the factors influencing
molecular subtlpes. Ki-67 expression is closely associated
with the gowth and invasion of breast cancer: Ki-6? positive
breast cancers are more active in growth, more aggressive in
invasion. and more metastatic [3, 7].
In conclusion, we found there is no correlation betrveen
higher expression of p53 and low expression of GATA-3 with
higher histopathology grading of breast cancer. High
expression of Ki-67 have significantly statistic analysis with
high expression of histopathology grading of mammary
cancer.
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